Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 115 participants.

Also called NCT04231084

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 115 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04231084
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04231084. Randomized; triple masking; primary purpose diagnostic. Start 2021-01-15 (actual); primary completion 2024-08-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide
Intervention (Drug)
Vasodilator testing (Inhaled Nitric Oxide)
Intervention (Drug)
Vasodilator testing (Inhaled Epoprostenol)
Lead sponsor
Brigham and Women's Hospital (class: other)

Record details

Record id
cardio:ct-nct04231084
Content hash
7946545d6e1da6f65f42fd773a8f0f10aa9a8a7af2778f46aa9f20eb6fb4d1f2